300 related articles for article (PubMed ID: 17332275)
1. Idiotype vaccination strategies in myeloma: how to overcome a dysfunctional immune system.
Rhee Fv
Clin Cancer Res; 2007 Mar; 13(5):1353-5. PubMed ID: 17332275
[No Abstract] [Full Text] [Related]
2. Long-term idiotype vaccination combined with interleukin-12 (IL-12), or IL-12 and granulocyte macrophage colony-stimulating factor, in early-stage multiple myeloma patients.
Hansson L; Abdalla AO; Moshfegh A; Choudhury A; Rabbani H; Nilsson B; Osterborg A; Mellstedt H
Clin Cancer Res; 2007 Mar; 13(5):1503-10. PubMed ID: 17332295
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy in multiple myeloma: current strategies and future prospects.
Yi Q
Expert Rev Vaccines; 2003 Jun; 2(3):391-8. PubMed ID: 12903804
[TBL] [Abstract][Full Text] [Related]
4. Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells.
Röllig C; Schmidt C; Bornhäuser M; Ehninger G; Schmitz M; Auffermann-Gretzinger S
J Immunother; 2011 Jan; 34(1):100-6. PubMed ID: 21150718
[TBL] [Abstract][Full Text] [Related]
5. Idiotypic vaccination as therapy for multiple myeloma.
Kwak LW; Thielemans K; Massaia M
Semin Hematol; 1999 Jan; 36(1 Suppl 3):34-7. PubMed ID: 9989488
[TBL] [Abstract][Full Text] [Related]
6. Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research.
Bogen B; Ruffini PA; Corthay A; Fredriksen AB; Frøyland M; Lundin K; Røsjø E; Thompson K; Massaia M
Haematologica; 2006 Jul; 91(7):941-8. PubMed ID: 16818282
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of hematological malignancies using dendritic cells.
Van de Velde AL; Berneman ZN; Van Tendeloo VF
Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412
[TBL] [Abstract][Full Text] [Related]
8. [The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells].
Ocadlíková D; Zahradová L; Kovárová L; Smejkalová J; Pour L; Vidláková P; Kyjovská D; Moravcová J; Rycová M; Novotná H; Jelínková I; Penka M; Michálek J; Hájek R
Klin Onkol; 2009; 22(2):67-72. PubMed ID: 19522376
[TBL] [Abstract][Full Text] [Related]
9. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study.
Reichardt VL; Okada CY; Liso A; Benike CJ; Stockerl-Goldstein KE; Engleman EG; Blume KG; Levy R
Blood; 1999 Apr; 93(7):2411-9. PubMed ID: 10090953
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of metastasis.
Dallal RM; Lotze MT
Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic cancer vaccines.
Morris LF; Ribas A
Surg Oncol Clin N Am; 2007 Oct; 16(4):819-31, ix. PubMed ID: 18022546
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic idiotype vaccines for non-Hodgkin's lymphoma.
Timmerman JM
Adv Pharmacol; 2004; 51():271-93. PubMed ID: 15464914
[No Abstract] [Full Text] [Related]
13. Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients.
Yi Q; Szmania S; Freeman J; Qian J; Rosen NA; Viswamitra S; Cottler-Fox M; Barlogie B; Tricot G; van Rhee F
Br J Haematol; 2010 Sep; 150(5):554-64. PubMed ID: 20618329
[TBL] [Abstract][Full Text] [Related]
14. Cancer vaccine strategies get bigger and better.
de Gruijl TD; Curiel DT
Nat Med; 1999 Oct; 5(10):1124-5. PubMed ID: 10502808
[No Abstract] [Full Text] [Related]
15. Vaccines for lymphomas: idiotype vaccines and beyond.
Houot R; Levy R
Blood Rev; 2009 May; 23(3):137-42. PubMed ID: 18951668
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in multiple myeloma immunotherapy.
Ruffini PA; Biragyn A; Kwak LW
Biomed Pharmacother; 2002 May; 56(3):129-32. PubMed ID: 12046683
[TBL] [Abstract][Full Text] [Related]
17. Idiotype vaccination for lymphoma: moving towards optimisation.
Houot R; Levy R
Leuk Lymphoma; 2009 Jan; 50(1):1-2. PubMed ID: 19172492
[No Abstract] [Full Text] [Related]
18. Idiotype vaccination in follicular lymphoma: knocking on the doorway to cure.
Longo DL
J Natl Cancer Inst; 2006 Sep; 98(18):1263-5. PubMed ID: 16985240
[No Abstract] [Full Text] [Related]
19. Active idiotype vaccination in multiple myeloma. GM-CSF may be an important adjuvant cytokine.
Mellstedt H; Osterborg A
Pathol Biol (Paris); 1999 Feb; 47(2):211-5. PubMed ID: 10192891
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of idiotype vaccination on the specific T-cell response in peripheral blood and bone marrow of multiple myeloma patients.
Abdalla AO; Hansson L; Eriksson I; Näsman-Glaser B; Mellstedt H; Osterborg A
Eur J Haematol; 2007 Nov; 79(5):371-81. PubMed ID: 17916084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
